Yamamoto Takaaki, Ugai Hideyo, Nakayama-Imaohji Haruyuki, Tada Ayano, Elahi Miad, Houchi Hitoshi, Kuwahara Tomomi
Department of Pharmacy, Kagawa University Hospital, 1750-1 Miki, Kagawa, 761-0793, Japan.
Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki, Kagawa, 761-0793, Japan.
Anaerobe. 2018 Apr;50:69-75. doi: 10.1016/j.anaerobe.2018.02.003. Epub 2018 Feb 9.
The human gut commensal Bacteroides fragilis produces sialidases that remove a terminal sialic acid from host-derived polysaccharides. Sialidase is considered to be involved in B. fragilis infection pathology. A native B. fragilis sialidase has been purified and characterized, and was shown to be post-translationally modified by glycosylation. However, the biochemical properties of recombinant B. fragilis sialidase expressed in a heterologous host remain uncharacterized. In this study, we examined the enzymatic properties of the 60-kDa sialidase NanH1 of B. fragilis YCH46, which was prepared as a recombinant protein (rNanH1) in Escherichia coli. In E. coli rNanH1 was expressed as inclusion bodies, which were separated from soluble proteins to allow solubilization of insoluble rNanH1 in a buffer containing 8 M urea and renaturation in refolding buffer containing 100 mM CaCl and 50 mM L-arginine. The specific activity of renatured rNanH1 measured using 4-methylumberiferyl-α-D-N-acetyl neuraminic acid as a substrate was 6.16 μmol/min/mg. The optimal pH of rNanH1 ranged from 5.0 to 5.5. The specific activity of rNanH1 was enhanced in the presence of calcium ions. rNanH1 preferentially hydrolyzed the sialyl α2,8 linkage and cleaved sialic acids from mucin and serum proteins (e.g., fetuin and transferrin) but not from α1-acid glycoprotein, which is similar to the previously observed biochemical properties for a native sialidase purified from B. fragilis SBT3182. The results and methods described in this study will be useful for preparing and characterizing recombinant proteins for other B. fragilis sialidase isoenzymes.
人类肠道共生菌脆弱拟杆菌可产生唾液酸酶,该酶能从宿主来源的多糖中去除末端唾液酸。唾液酸酶被认为与脆弱拟杆菌感染病理学有关。一种天然的脆弱拟杆菌唾液酸酶已被纯化和鉴定,并显示其经过糖基化的翻译后修饰。然而,在异源宿主中表达的重组脆弱拟杆菌唾液酸酶的生化特性仍未得到表征。在本研究中,我们检测了脆弱拟杆菌YCH46的60 kDa唾液酸酶NanH1的酶学特性,该酶是以重组蛋白(rNanH1)的形式在大肠杆菌中制备的。在大肠杆菌中,rNanH1以包涵体形式表达,将其与可溶性蛋白分离,以便在含有8 M尿素的缓冲液中溶解不溶性rNanH1,并在含有100 mM CaCl和50 mM L-精氨酸的复性缓冲液中复性。以4-甲基伞形酮基-α-D-N-乙酰神经氨酸为底物测定复性后rNanH1的比活性为6.16 μmol/min/mg。rNanH1的最适pH范围为5.0至5.5。在钙离子存在下,rNanH1的比活性增强。rNanH1优先水解唾液酸α2,8连接,并从粘蛋白和血清蛋白(如胎球蛋白和转铁蛋白)中裂解唾液酸,但不能从α1-酸性糖蛋白中裂解唾液酸,这与之前从脆弱拟杆菌SBT3182中纯化的天然唾液酸酶的生化特性相似。本研究中描述的结果和方法将有助于制备和鉴定其他脆弱拟杆菌唾液酸酶同工酶的重组蛋白。